Company / Cash & Equivalents
GENESCO INC Cash & Equivalents History
FY2016-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$105.4M
FY2026
5-year range
$34.0M / $320.5M
FY2022-FY2026
Trend
+210.0%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents changed +210% YoY in FY2026, a notable deviation from the 9-year average annual change of +49%.
Based on SEC 10-K filings.
$105M in FY2026 with a 10-year CAGR of -2.3%.
Improved from $34M to $105M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +44.2%
- 5-Year CAGR
- -13.3%
- 10-Year CAGR
- -2.3%
Key checks
Key Insights
- 5-year CAGR of -13.3%, indicating a declining trend.
- In FY2026, cash & equivalents increased 210.0% year-over-year.
- Peak cash & equivalents was recorded in FY2022.
- Lowest cash & equivalents in the period was in FY2025.
Company context
Key Data Points
- Altman Z-Score 0.57 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $105.4M | +210.0% |
| FY2025 | $34.0M | +0.0% |
| FY2024 | $34.0M | -3.3% |
| FY2023 | $35.2M | -89.0% |
| FY2022 | $320.5M | +49.0% |
| FY2021 | $215.1M | +0.0% |
| FY2020 | $215.1M | +28.5% |
| FY2018 | $167.4M | +319.0% |
| FY2017 | $39.9M | -70.0% |
| FY2016 | $133.3M | +18.1% |
As of FY2026 · SEC Form 10-K · Last checked Jun 21, 2026